SP:T14 Tianjin Zhong Xin Pharmaceutical Group Corporation Limited

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, an investment holding company, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People's Republic of China. It is also involved in the manufacture and sale of biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, the company provides logistics, stocks, equipment installation, and medicine processing services. Tianjin Zhongxin Pharmaceutical Group Corporation Limited sells medicinal products under its own brand and other brands to wholesalers. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.

1.05 SGD
As of 12/07/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  01/04/2000
Stock exchange:    Singapore Exchange
Exchange country:   Singapore
Market cap:   2,413,410,053 SGD
Current dividend yield:   28.04%
CUSIP:    
ISIN:        CNE100000924
Sedol:      B2Q7X98

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy